All Stories

  1. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
  2. Ictal and interictal SPECT with 99mTc‐HMPAO in presurgical epilepsy. II: Methodological considerations on hyper‐ and hypoperfusion
  3. Ictal and interictal SPECT with 99mTc‐HMPAO in presurgical epilepsy. I: Predictive value and methodological considerations
  4. The history of Danish neuroscience
  5. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression
  6. Single-Voxel MR Spectroscopy of Gliomas with s-LASER at 7T
  7. Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study
  8. Correction: Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinated fasciculus microstructure
  9. Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration
  10. Human Cerebral Perfusion, Oxygen Consumption, and Lactate Production in Response to Hypoxic Exposure
  11. Do glia provide the link between low‐grade systemic inflammation and normal cognitive ageing? A 1 H magnetic resonance spectroscopy study at 7 tesla
  12. Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy
  13. Glucocorticoid treatment for non-cerebral diseases in children and adolescents is associated with differences in uncinate fasciculus microstructure
  14. Interictal pontine metabolism in migraine without aura patients: A 3 Tesla proton magnetic resonance spectroscopy study
  15. Feasibility of Glutamate and GABA Detection in Pons and Thalamus at 3T and 7T by Proton Magnetic Resonance Spectroscopy
  16. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing
  17. Blood pressure and brain injury in cardiac surgery: a secondary analysis of a randomized trial
  18. Intradural artery dilation during experimentally induced migraine attacks
  19. Transcranial low‐frequency pulsating electromagnetic fields (T‐PEMF) as post‐concussion syndrome treatment
  20. Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labeling
  21. Cigarette smoking and cerebral blood flow in a cohort of middle-aged adults
  22. Regional glia-related metabolite levels are higher at older age and scale negatively with visuo-spatial working memory: A cross-sectional proton MR spectroscopy study at 7 tesla on normal cognitive ageing
  23. Diagnostic yield of high-density versus low-density EEG: The effect of spatial sampling, timing and duration of recording
  24. Diagnostic added value of electrical source imaging in presurgical evaluation of patients with epilepsy: A prospective study
  25. The association between postoperative cognitive dysfunction and cerebral oximetry during cardiac surgery: a secondary analysis of a randomised trial
  26. No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intake
  27. Brain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed
  28. Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study
  29. Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study
  30. Domain‐specific cognitive dysfunction after cardiac surgery. A secondary analysis of a randomized trial
  31. Previous glucocorticoid treatment in childhood and adolescence is associated with long-term differences in subcortical grey matter volume and microstructure
  32. Neuroticism predicts the impact of serotonin challenges on fear processing in subgenual anterior cingulate cortex
  33. Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy
  34. Gamma‐aminobutyric acid edited echo‐planar spectroscopic imaging (EPSI) with MEGA‐sLASER at 7T
  35. Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers
  36. Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T
  37. Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study
  38. Verbal learning and memory outcome in selective amygdalohippocampectomy versus temporal lobe resection in patients with hippocampal sclerosis
  39. High-Target vs Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients - A Randomized Controlled Trial
  40. Total brain, cortical, and white matter volumes in children previously treated with glucocorticoids
  41. Neural Response After a Single ECT Session During Retrieval of Emotional Self-Referent Words in Depression: A Randomized, Sham-Controlled fMRI Study
  42. Glucocorticoid treatment earlier in childhood and adolescence show dose-response associations with diurnal cortisol levels
  43. Imaging Regional Metabolic Changes in the Ischemic Rat Heart In Vivo Using Hyperpolarized [1- 13 C]Pyruvate
  44. Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla
  45. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study
  46. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders
  47. Perfusion Pressure Cerebral Infarct (PPCI) trial - the importance of mean arterial pressure during cardiopulmonary bypass to prevent cerebral complications after cardiac surgery: study protocol for a randomised controlled trial
  48. Neural correlates of improved executive function following erythropoietin treatment in mood disorders
  49. The Center for Integrated Molecular Brain Imaging (Cimbi) database
  50. Design of Infusion Schemes for Neuroreceptor Imaging: Application to [11C]Flumazenil-PET Steady-State Study
  51. Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
  52. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
  53. Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression
  54. Children and adolescents previously treated with glucocorticoids display lower verbal intellectual abilities
  55. Shape Abnormalities of the Caudate Nucleus Correlate with Poorer Gait and Balance: Results from a Subset of the LADIS Study
  56. Interpolation of diffusion weighted imaging datasets
  57. CorticalN-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis
  58. Monitoring mammary tumor progression and effect of tamoxifen treatment in MMTV‐PymT using MRI and magnetic resonance spectroscopy with hyperpolarized [1‐13C]pyruvate
  59. Multiple sclerosis impairs regional functional connectivity in the cerebellum
  60. Bradykinin Antagonist Counteracts the Acute Effect of Both Angiotensin-Converting Enzyme Inhibition and of Angiotensin Receptor Blockade on the Lower Limit of Autoregulation of Cerebral Blood Flow
  61. Serotonin 2A receptors contribute to the regulation of risk-averse decisions
  62. In Memoriam: Bo K Siesjö, 1930–2013
  63. Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion
  64. A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging
  65. Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression
  66. Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala
  67. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study
  68. Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks
  69. Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis
  70. Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: A longitudinal analysis
  71. Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis
  72. Serotonin 2A Receptors, Citalopram and Tryptophan-Depletion: a Multimodal Imaging Study of their Interactions During Response Inhibition
  73. Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis
  74. Healthy aging attenuates task-related specialization in the human medial temporal lobe
  75. No change in [11C]CUMI-101 binding to 5-HT1A receptors after intravenous citalopram in human
  76. The cortical eye proprioceptive signal modulates neural activity in higher-order visual cortex as predicted by the variation in visual sensitivity
  77. Sandstone hosted uranium deposits of the Great Divide Basin, Wyoming, USA
  78. Activation of the hippocampal complex during tactile maze solving in congenitally blind subjects
  79. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study
  80. Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis
  81. The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study
  82. Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study
  83. Crossmodal Recruitment of the Ventral Visual Stream in Congenital Blindness
  84. Neural Metabolism In Vivo
  85. History of International Society for Cerebral Blood Flow and Metabolism
  86. The Coupling of Cerebral Metabolic Rate of Glucose and Cerebral Blood Flow In Vivo
  87. White matter hyperintensities and prepulse inhibition in a mixed elderly population
  88. Postoperative increase in grey matter volume in visual cortex after unilateral cataract surgery
  89. Exogenous glucocorticoids and adverse cerebral effects in children
  90. White Matter Microstructure in Superior Longitudinal Fasciculus Associated with Spatial Working Memory Performance in Children
  91. Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: A 3-year follow-up of the LADIS study cohort
  92. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue
  93. Neural correlates of olfactory processing in congenital blindness
  94. Incident lacunes influence cognitive decline: The LADIS study
  95. Monocular Visual Deprivation Suppresses Excitability in Adult Human Visual Cortex
  96. 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?
  97. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
  98. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding
  99. White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study
  100. Hippocampal volume changes in healthy subjects at risk of unipolar depression
  101. Neural correlates of virtual route recognition in congenital blindness
  102. Response inhibition is associated with white matter microstructure in children
  103. Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia
  104. Methods for observing the living brain
  105. Regional activation of the human medial temporal lobe during intentional encoding of objects and positions
  106. Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding
  107. Cerebral Blood Flow Response to Functional Activation
  108. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study
  109. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram vers...
  110. No Evidence for Generalized Increased Postoperative Responsiveness to Pain: A Combined Behavioral and Serial Functional Magnetic Resonance Imaging Study
  111. Corrigendum to “Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use” [NeuroImage 46 (2009) 23–30]
  112. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort
  113. Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use
  114. A Case of Malignant Lymphoma and Myasthenia Gravis
  115. THE EFFECTS OF SODIUM NITROPRUSSIDE ON CEREBRAL BLOOD FLOW AND CEREBRAL VENOUS BLOOD GASES IN MAN
  116. ACID-BASE PATTERN OF CEREBROSPINAL FLUID AND ARTERIAL BLOOD IN BACTERIAL MENINGITIS AND IN ENCEPHALITIS
  117. REGIONAL CEREBRAL BLOOD FLOW, CEREBRAL METABOLIC RATE OF OXYGEN, AND CEREBROSPINAL FLUID ACID-BASE VARIABLES IN PATIENTS WITH ACUTE MENINGITIS AND WITH ACUTE ENCEPHALITIS
  118. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
  119. Transfer of bromocriptine across the blood-brain barrier in man
  120. Skeletal muscle in paramyotonia congenita: biochemistry, histochemistry and morphology
  121. PHYSIOLOGIC AND PATHOPHYSIOLOGIC RELATIONSHIP BETWEEN THE ELECTROENCEPHALOGRAM AND THE REGIONAL CEREBRAL BLOOD FLOW
  122. METRIZAMID MYELOGRAPHY IN PATIENTS WITH MENINGEAL CARCINOMATOSIS
  123. MECHANISM OF ACTION OF AMINO-PHYLLINE AND OF HYPOCAPNIA ON CEREBROVASCULAR DISEASE
  124. 875 CASES OF BACTERIAL MENINGITIS AT THE BLEGDAMSHOSPITAL 1966-76. PROGNOSIS AND FOLLOW-UP.
  125. CHARACTERISTICS OF THE GRADUALLY SPREADING REDUCTION OF REGIONAL CEREBRAL BLOOD FLOW IN CLASSIC MIGRAINE.
  126. Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents
  127. ELECTROPHYSIOLOGICAL FINDINGS IN MYASTHENIA GRAVIS FOLLOWING PLASMA EXCHANGE
  128. INTRACRANIAL METASTASES IN SMALL CELL LUNG CANCER.
  129. MISONIDAZOLE NEUROPATHY - A PROSPECTIVE STUDY:
  130. MISONIDAZOLE NEUROPATHY:
  131. PLASMA PYRIDOSTIGMINE LEVELS IN MYASTHENIA GRAVIS.
  132. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography
  133. Differences in Characteristics of Blood-Brain Barrier Permeability for Glucose and Amino Acids
  134. The Effect of Extracranial-intracranial Bypass on Cerebral Blood Flow
  135. BRAIN MAPPING BY EMISSION COMPUTERIZED TOMOGRAPHY: (ECT) OF INHALED 133-XENON DURING ACTIVATION OF THE BRAIN CORTEX.
  136. CEREBRAL UPTAKE RATE OF ANTIEPILEPTIC DRUGS
  137. CHANGES IN FOCAL CEREBRAL BLOOD FLOW WITHIN THE INTERNAL CAROTID SYSTEM DURING MIGRAINE ATTACK
  138. FOCAL CEREBRAL BLOOD FLOW, REACTIVITY OF CEREBRAL BLOOD VESSELS AND CEREBRAL OXYDATIVE METABOLISM IN CERTAIN GROUPS OF PATIENTS WITH ORGANIC DEMENTIA
  139. MRI-Defined Subcortical Ischemic Vascular Disease: Baseline Clinical and Neuropsychological Findings
  140. Longitudinal Cognitive Decline in Subcortical Ischemic Vascular Disease – The LADIS Study
  141. Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates
  142. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
  143. Urinary Complaints in Nondisabled Elderly People with Age-Related White Matter Changes: The Leukoaraiosis And DISability (LADIS) Study
  144. On the Etiology of Incident Brain Lacunes: Longitudinal Observations From the LADIS Study
  145. White Matter Changes Contribute to Corpus Callosum Atrophy in the Elderly: The LADIS Study
  146. Comments on Point:Counterpoint: Sympathetic activity does/does not influence cerebral blood flow
  147. Heart and brain circulation in healthy men are differently affected by CO2
  148. Segmentation of age-related white matter changes in a clinical multi-center study
  149. The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined
  150. Association of gait and balance disorders with age-related white matter changes: The LADIS Study
  151. Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study
  152. Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder
  153. Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study
  154. Alterations of the visual pathways in congenital blindness
  155. Reliability and Sensitivity of Visual Scales versus Volumetry for Evaluating White Matter Hyperintensity Progression
  156. Acute MRI Changes in Progressive Ischemic Stroke
  157. Is the Prefrontal Cortex Necessary for Establishing Cognitive Sets?
  158. Validation of in vitro probabilistic tractography
  159. Premotor cortex modulates somatosensory cortex during voluntary movements without proprioceptive feedback
  160. Watching Your Foot Move--An fMRI Study of Visuomotor Interactions during Foot Movement
  161. Structural brain abnormalities in early onset first-episode psychosis
  162. P2-253
  163. A prospective PET study of patients with glioblastoma multiforme
  164. Similar brain networks for detecting visuo-motor and visuo-proprioceptive synchrony
  165. Motor activation in SPG4-linked hereditary spastic paraplegia
  166. Correlation of Global N-Acetyl Aspartate With Cognitive Impairment in Multiple Sclerosis
  167. Global Cerebral Blood Flow and Metabolism during Acute Hyperketonemia in the Awake and Anesthetized Rat
  168. Magnetic Resonance Imaging at 3.0 Tesla Detects More Lesions in Acute Optic Neuritis Than at 1.5 Tesla
  169. Shape configuration and category-specificity
  170. Increased intracranial volume in Parkinson's disease
  171. Changes in BOLD and ADC weighted imaging in acute hypoxia during sea-level and altitude adapted states
  172. Decline in intelligence is associated with progression in white matter hyperintensity volume
  173. MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS)
  174. Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia
  175. Global Cerebral Blood Flow and Metabolism during Acute Hyperketonemia in the Awake and Anesthetized Rat
  176. White matter hyperintensities and depression—preliminary results from the LADIS study
  177. Motion or activity: their role in intra- and inter-subject variation in fMRI
  178. Laser Doppler flowmetry is valid for measurement of cerebral blood flow autoregulation lower limit in rats
  179. Assessment of in vivo MR imaging compared to physical sections in vitro—A quantitative study of brain volumes using stereology
  180. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
  181. The relationship between cerebral blood flow and volume in humans
  182. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis
  183. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation
  184. Enhanced Accuracy in Novel Mirror Drawing after Repetitive Transcranial Magnetic Stimulation-Induced Proprioceptive Deafferentation
  185. Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences
  186. [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge
  187. Right Temporoparietal Cortex Activation during Visuo-proprioceptive Conflict
  188. Parieto–Occipital Areas Involved in Efficient Filtering in Search: A Time Course Analysis of Visual Marking using Behavioural and Functional Imaging Procedures
  189. A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables
  190. Structural similarity and category-specificity: a refined account
  191. Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats
  192. Blood–brain barrier, brain metabolism and cerebral blood flow
  193. Attentional effects in the visual pathways: a whole-brain PET study
  194. When Action Turns into Words. Activation of Motor-Based Knowledge during Categorization of Manipulable Objects
  195. Cortical Deactivation Induced by Visual Stimulation in Human Slow-Wave Sleep
  196. Regional cerebral blood flow during light sleep - a H215O-PET study
  197. Regulation of cerebral blood flow in patients with autonomic dysfunction and severe postural hypotension
  198. Hemodynamic and metabolic features of cerebral activation
  199. Oxygen delivery to the brain during behavioral activation at acute normobaric hypoxemia
  200. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat
  201. Quantification of [123I]PE2I binding to dopamine transporters with SPET
  202. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats
  203. Cluster analysis of activity-time series in motor learning
  204. Unchanged Cerebral Blood Flow and Oxidative Metabolism after Acclimatization to High Altitude
  205. The Role of Action Knowledge in the Comprehension of Artefacts— A PET Study
  206. Brain activity related to integrative processes in visual object recognition: bottom-up integration and the modulatory influence of stored knowledge
  207. Activation-Induced Resetting of Cerebral Metabolism and Flow Is Abolished by  -Adrenergic Blockade With Propranolol
  208. Idiopathic normal-pressure hydrocephalus: evaluation and findings in a multidisciplinary memory clinic
  209. EFNS Task Force on Teaching of Neuroimaging in Neurology Curricula in Europe: present status and recommendations for the future
  210. No effect of angiotensin II AT2-receptor antagonist PD 123319 on cerebral blood flow autoregulation
  211. Using 10CO2 for Single Subject Characterization of the Stimulus Frequency Dependence in Visual Cortex: A Novel Positron Emission Tomography Tracer for Human Brain Mapping
  212. The 18F-fluorodeoxyglucose Lumped Constant Determined in Human Brain from Extraction Fractions of 18F-fluorodeoxyglucose and Glucose
  213. Integrative processes in visual object recognition
  214. Modified motor activation in autosomal dominant pure spastic paraplegia (ADPSP) using PET
  215. Blood-Brain Barrier Transport and Brain Metabolism of Glucose during Acute Hyperglycemia in Humans
  216. Benzodiazepine receptor quantification in Huntington's disease with [123I]iomazenil and SPECT
  217. Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the ε4 Allele on Regional Cerebral Blood Flow
  218. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
  219. Categorization and category effects in normal object recognition
  220. Brain Activation During Mental Transformation of Size
  221. Quantitation of Regional Cerebral Blood Flow Corrected for Partial Volume Effect Using O-15 Water and PET: II. Normal Values and Gray Matter Blood Flow Response to Visual Activation
  222. Quantitation of Regional Cerebral Blood Flow Corrected for Partial Volume Effect Using O-15 Water and PET: I. Theory, Error Analysis, and Stereologic Comparison
  223. Dopamine D2 receptor quantification in extrastriatal brain regions using [123I]epidepride with bolus/infusion
  224. Dopamine D2 receptor quantification in extrastriatal brain regions using [123I]epidepride with bolus/infusion
  225. Effects of attention on dichotic listening: An15O-PET study
  226. The role of action knowledge in the comprehension of artefacts— A PET study
  227. Attentional modulation in the early visual pathways
  228. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate
  229. Cerebral activation during micturition in normal men
  230. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS
  231. Regional Differences in the CBF and BOLD Responses to Hypercapnia: A Combined PET and fMRI Study
  232. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
  233. Reconstruction strategy for echo planar spectroscopy and its application to partially undersampled imaging
  234. Perceptual differentiation and category effects in normal object recognition: A PET study
  235. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
  236. Blood—Brain Barrier Transport and Protein Binding of Flumazenil and Iomazenil in the Rat: Implications for Neuroreceptor Studies
  237. High dose insulin does not increase glucose transfer across the blood-brain barrier in humans: a re-evaluation
  238. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS
  239. Determination of relative CMRO2 from CBF and BOLD changes: Significant increase of oxygen consumption rate during visual stimulation
  240. A multidisciplinary memory clinic in a neurological setting: diagnostic evaluation of 400 consecutive patients
  241. Generalizable Patterns in Neuroimaging: How Many Principal Components?
  242. Brain activation during dichotic presentations of consonant-vowel and musical instrument stimuli: a 15O-PET study
  243. The Kety–Schmidt technique for repeated measurements of global cerebral blood flow and metabolism in the conscious rat
  244. Maturation Phenomenon in Cerebral Ischemia III
  245. Parieto-occipital cortex activation during self-generated eye movements in the dark
  246. Differential Effects of Migraine Drugs on Cerebral Blood Flow Autoregulation
  247. Activation-Induced Resetting of Cerebral Oxygen and Glucose Uptake in the Rat
  248. Brain Activation during Word Identification and Word Recognition
  249. Calculation of the FDG Lumped Constant by Simultaneous Measurements of Global Glucose and FDG Metabolism in Humans
  250. Cerebral blood volume in humans by NIRS and PET
  251. Functional Brain Imaging With Single-Photon Emission Computed Tomography in the Diagnosis of Alzheimers Disease
  252. The activation pattern in normal humans during suppression, imagination and performance of saccadic eye movements
  253. Niels A. Lassen, M.D., Ph.D. 1926–1997
  254. Differential Effects of Increasing Doses of α-Trinositol on Cerebral Blood Flow Autoregulation
  255. Cerebral metabolism in a case of multiple sclerosis with acute mental disorder
  256. Rate Dependence of Regional Cerebral Activation during Performance of a Repetitive Motor Task: A PET Study
  257. Interictal SPECT of rCBF is of clinical utility in the preosperative evaluation of patients with partial epilepsy
  258. Antihypertensive drugs and cerebral circulation
  259. Dissociated cerebral vasoparalysis in acute liver failure
  260. Transport of D-Glucose and 2-Fluorodeoxyglucose across the Blood-Brain Barrier in Humans
  261. Cerebral Glucose Metabolism Is Decreased in White Matter Changes in Patients with Phenylketonuria
  262. EC-IC bypass in patients with chronic hemodvnamic insufficiency
  263. Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus.
  264. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria
  265. Cerebral blood flow in untreated and treated hypertension
  266. Cerebral blood flow autoregulation and transcranial doppler sonography in patients with cirrhosis*1
  267. Neuroreceptor quantification in vivo by the steady state principle and [123I]iomazenil in rats
  268. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans
  269. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation
  270. Persistent Resetting of the Cerebral Oxygen/Glucose Uptake Ratio by Brain Activation: Evidence Obtained with the Kety—Schmidt Technique
  271. Cerebrovascular Damage in Hypertension
  272. Cerebrovascular damage in hypertension
  273. Regional Cerebral Blood Flow and Neuropsychological Performance in a Danish Family with X-Linked Bulbo-Spinal Neuronopathy
  274. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
  275. Hypercapnic vasodilatation in isolated rat basilar arteries is exerted via low pH and does not involve nitric oxide synthase stimulation or cyclic GMP production
  276. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation
  277. Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type
  278. Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats
  279. Cerebrovascular consequences of hypertension
  280. Comparison of the effects of NG-nitro-L-arginine and indomethacin on the hypercapnic cerebral blood flow increase in rats
  281. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
  282. Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure
  283. Cerebral Ischemia and Basic Mechanisms
  284. The Effect of Tirilazad Mesylate (U74006F) on Cerebral Oxygen Consumption, and Reactivity of Cerebral Blood Flow to Carbon Dioxide in Healthy Volunteers
  285. Indomethacin Abolishes Cerebral Blood Flow Increase in Response to Acetazolamide-Induced Extracellular Acidosis: A Mechanism for its Effect on Hypercapnia?
  286. High resolution SPECT with [99mTc]-d,l-HMPAO in normal pressure hydrocephalus before and after shunt operation.
  287. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy
  288. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy
  289. Ceranapril and cerebral blood flow autoregulation
  290. Thalamic infarcts: Effects on cerebral blood flow, metabolism, and neuropsychological function
  291. Nitric oxide does not act as a mediator coupling cerebral blood flow to neural activity following somatosensory stimuli in rats
  292. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.
  293. Effect of Nitric Oxide Blockade by NG-Nitro-l-Arginine on Cerebral Blood Flow Response to Changes in Carbon Dioxide Tension
  294. Increased Cerebral Blood Flow in Anemic Patients on Long-Term Hemodialytic Treatment
  295. Is autoregulation of cerebral blood flow in rats influenced by nitro-l-arginine, a blocker of the synthesis of nitric oxide?
  296. The effect of ketanserin on cerebral blood flow and cerebrovascular CO2 reactivity in healthy volunteers
  297. Cerebral Blood Flow Deficits in Hereditary Essential Myoclonus
  298. Extracranial-Intracranial Bypass Revisited
  299. Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats
  300. Effect of ketanserin on cerebral blood flow autoregulation in healthy volunteers
  301. Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population Survey
  302. Kinetic Analysis of the Human Blood-Brain Barrier Transport of Lactate and its Influence by Hypercapnia
  303. Regional Density of Perfused Capillaries and Cerebral Blood Flow in Untreated Short-Term and Long-Term Streptozotocin Diabetes
  304. 99mTc-d,l-HMPAO and SPECT of the Brain in Normal Aging
  305. The acute effect of nimodipine on cerebral blood flow, its CO2 reactivity, and cerebral oxygen metabolism in human volunteers
  306. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors
  307. Effect of acute and prolonged treatment with propranolol on cerebral blood flow and cerebral oxygen metabolism in healthy volunteers
  308. Asymmetrical Transport of Amino Acids across the Blood—Brain Barrier in Humans
  309. The Effect of Fosinopril Sodium on Cerebral Blood Flow in Moderate Essential Hypertension
  310. Computerized Analysis of Cerebral Blood Flow Autoregulation in Humans
  311. The Acute Effect of Dilevalol on Cerebral Blood Flow and Oxygen Consumption in Normotensive Humans
  312. Angiotensin converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalus
  313. Kinetic analysis of blood-brain barrier transport of d-glucose in man: Quantitative evaluation in the presence of tracer backflux and capillary heterogeneity
  314. Involuntary Movements
  315. Angiotensin-Converting Enzyme Inhibition and Regional Cerebral Blood Flow in Acute Stroke
  316. Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation
  317. Neuronal pH Regulation: Constant Normal Intracellular pH is Maintained in Brain during Low Extracellular pH Induced by Acetazolamide—31P NMR Study
  318. Cerebral circulation under normal and pathologic conditions
  319. Angiotensin converting enzyme inhibition and cerebral circulation-a review.
  320. Metabolic Disturbances of the Blood-Brain Barrier with Special Emphasis on Glucose and Amino Acid Transport
  321. Cerebral Ischemia and Calcium
  322. Misonidazole neuropathy A prospective study
  323. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy
  324. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow?
  325. Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting
  326. Methods for Measurement of Cerebral Blood Flow
  327. Antihypertensive Treatment and the Cerebral Circulation
  328. Antihypertensive Treatment and the Cerebral Circulation
  329. Methods for Measurement of Cerebral Blood Flow
  330. Decreased Blood-Brain Barrier Permeability to Sodium in Early Experimental Diabetes
  331. Cerebral blood flow in acute and chronic ischemic stroke using xenon-133 inhalation tomography
  332. DOES ANGIOTENSIN-II PROTECT AGAINST STROKES?
  333. Effect of captopril on the cerebral circulation in chronic heart failure
  334. Calcium Antagonist (PY 108-068) Treatment May Further Decrease Flow in Ischemic Areas in Acute Stroke
  335. Regional cerebral blood flow in acute experimental allergic encephalomyelitis
  336. A Spatial Analysis of the Blood—Brain Barrier Damage in Experimental Allergic Encephalomyelitis
  337. Observations on regional cerebral blood flow in cortical and subcortical structures during language production in normal man
  338. CBF before and after extracranial-intracranial bypass surgery in patients with ischemic cerebrovascular disease studied with 133Xe- inhalation tomography
  339. Pneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae
  340. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri)
  341. FOCAL INCREASE OF BLOOD FLOW IN THE CEREBRAL CORTEX OF MAIN DURING VESTIBULAR STIMULATION
  342. Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis
  343. Cerebral Blood Flow and Metabolism Measurement
  344. Cerebrovascular Aspects of Converting-enzyme Inhibition II: Blood-brain Barrier Permeability and Effect of Intracerebroventricular Administration of Captopril
  345. Cerebrovascular Aspects of Converting-enzyme Inhibition I: Effects of Intravenous Captopril in Spontaneously Hypertensive and Normotensive Rats
  346. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen.
  347. Pneumococcal Meningitis
  348. Steady state kinetics of pyridostigmine in myasthenia gravis
  349. Converting Enzyme Inhibition and Autoregulation of Cerebral Blood Flow in Spontaneously Hypertensive and Normotensive Rats
  350. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat
  351. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats
  352. Cerebral blood flow in patients with congestive heart failure treated with captopril
  353. Cerebral autoregulation
  354. Regional Cerebral Blood Flow Measured by Xenon-133 and [123I]Iodo-Amphetamine in Patients with Cerebrovascular Diseases
  355. Cerebral blood flow during dihydralazine-induced hypotension in hypertensive rats
  356. Regulation of regional cerebral blood flow during and between migraine attacks
  357. Whole blood viscosity and cerebral blood flow
  358. Secondary brain stem hemorrhage in stroke
  359. Changes in regional cerebral blood flow during the course of classic migraine attacks
  360. Intracranial metastases in small cell carcinoma of the lung prognostic aspects
  361. Controlled Hypotension with Sodium Nitroprusside: Effects on Cerebral Blood Flow and Cerebral Venous Blood Gases in Patients Operated for Cerebral Aneurysms
  362. The Indicator Dilution Method: Assumptions and Applications to Brain Uptake
  363. Tracer Kinetics and Physiologic Modeling
  364. Intracranial metastases in small cell carcinoma of the lung. Correlation of clinical and autopsy findings
  365. Transfer across the human blood-brain barrier: Evidence for capillary recruitment and for a paradox glucose permeability increase in hypocapnia
  366. The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases.
  367. The effects of sodium nitroprusside on cerebral blood flow and cerebral venous blood gases.
  368. Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs
  369. Arterial and venous concentrations of phenobarbital, phenytoin, clonazepam, and diazepam after rapid intravenous injections
  370. Letter to the Editor
  371. Misonidazole neuropathy: A clinical, electrophysiological and histological study
  372. Invasive Adenoma of the Pituitary Gland and Chronic Migrainous Neuralgia. A Rare Coincidence or a Causal Relationship?
  373. Rapid improvement of myasthenia gravis after plasma exchange
  374. Amphotericin B and the Blood-Brain Barrier to Methotrexate
  375. Amphotericin B and the Blood-Brain Barrier to Methotrexate
  376. Reply
  377. Visual cortex activation recorded by dynamic emission computed tomography of inhaled xenon 133
  378. Note by Editors-in-Chief
  379. Blood-brain barrier permeability of L-dopa in man
  380. Cerebral blood flow following normavolemic hemodilution in patients with high hematocrit
  381. Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography
  382. Insulin increases glucose transfer across the blood-brain barrier in man.
  383. Essential tremor treated with propranolol: Lack of correlation between clinical effect and plasma propranolol levels
  384. The role of unstirred layers for water exchange across the blood-brain barrier
  385. Orbital bruits and retinal artery pressure in internal carotid artery occlusion
  386. insulin influence the cerebral uptake of glucose.
  387. RECENT ADVANCES IN THE DIAGNOSIS OF CEREBROVASCULAR DISEASE
  388. THE BLOOD-BRAIN BARRIER:AN OVERVIEW WITH SPECIAL REFERNCE TO INSULIN EFFECTS ON GLUCOSE TRANSPORT
  389. Carbon dioxide permeability of the blood-brain barrier in man
  390. Heterogeneity of cerebral capillary flow in man and its consequences for estimation of blood-brain barrier permeability.
  391. CEREBROVASCULAR RESPONSES: MISCELLANEOUS TOPICS
  392. Neuro-Oncology
  393. CHAPTER X: CEREBROVASCULAR RESPONSES: MISCELLANEOUS TOPICS
  394. Blood-brain barrier permeability during shortlasting intravascular hyperosmolality
  395. CHAPTER VIII STROKE
  396. DOES ALEXIA WITHOUT AGRAPHIA ALWAYS INCLUDE HEMIANOPSIA?
  397. The permeability of the blood—brain barrier during electrically induced seizures in man
  398. Filtration and diffusion of water across the blood-brain barrier in man
  399. Ophthalmodynamometry in internal carotid artery occlusion
  400. NATURAL HISTORY OF MICTURITION SYNCOPE
  401. Cerebral Circulation and Metabolism
  402. The Mechanism of Cerebral Hyperemia in Electrically Induced Epileptic Seizures in Man
  403. Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls
  404. Traitements des maladies cérébro-vasculaires : aperçus au sujet des lésions ischémiques et des hématomes intracérébraux
  405. Regional cerebral blood flow in cerebral infarction and in transient ischemic attacks
  406. Normal and abnormal relationship between the electroencephalogram (EEG) and the regional cerebral blood flow (rCBF)
  407. Conclusions générales
  408. Cerebral Vasomotor Paralysis During Migraine Attack
  409. CEREBRAL BLOOD FLOW AND METABOLISM IN ELECTROCONVULSIVE THERAPY
  410. Cerebral Apoplexy (Stroke) Treated With or Without Prolonged Artificial Hyperventilation: 2. Cerebrospinal Fluid Acid-Base Balance and Intracranial Pressure
  411. Cerebral Apoplexy (Stroke) Treated With or Without Prolonged Artificial Hyperventilation: 1. Cerebral Circulation, Clinical Course, and Cause of Death
  412. Cerebral Hyperemia in Electrically Induced Epileptic Seizures
  413. The Effect of Intracarotid Aminophylline Infusion on the Cerebral Circulation
  414. Prolonged Artificial Hyperventilation in Severe Cerebral Apoplexy
  415. Restoration of autoregulation of cerebral blood flow by hypocapnia
  416. Intracranial Hypertension
  417. Regional Cerebral Blood Flow in Man Determined by the Initial Slope of the Clearance of Intra-arterially Injected l33Xe: THEORY OF THE METHOD, NORMAL VALUES, ERROR OF MEASUREMENT, CORRECTION FOR REMAINING RADIOACTIVITY, RELATION TO OTHER FLOW PARAMETER...
  418. Cerebral Apoplexy (Stroke): Pathogenesis, Pathophysiology and Therapy as Illustrated by Regional Blood Flow Measurements in the Brain
  419. The Effect of Intra-arterial Papaverine on the Regional Cerebral Blood Flow in Patients with Stroke or Intracranial Tumor
  420. REGIONAL CEREBRAL BLOOD FLOW AND ITS REGULATION IN DEMENTIA
  421. TOTAL CO2, LACTATE, AND PYRUVATE IN BRAIN BIOPSIES TAKEN AFTER FREEZING THE TISSUE IN SITU
  422. THE MECHANISM OF ACTION OF AMINOPHYLLINE UPON CEREBRAL VASCULAR DISORDERS
  423. Regional cerebral blood flow and its autoregulation in patients with transient focal cerebral ischemic attacks
  424. Regional cerebral blood flow in apoplexy without arterial occlusion
  425. Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery
  426. Regional blood flow in internal carotid distribution during migraine attack.
  427. Carbon Dioxide and Cerebral Circulatory Control
  428. THE METABOLISM OF GLUCOSE AND OTHER METABOLITES IN THE BRAIN OF PATIENTS WITH CEREBRAL ARTERIOSCLEROSIS AND OF PATIENTS WITH DIABETES MELLITUS
  429. The Local Site of Action of CO2on Cerebral Circulation Evidenced by Changing the Internal Carotid Artery pCO2in Awake Human Subjects
  430. Regional Cerebral Blood Flow in Middle Cerebral Artery Occlusion
  431. Regional Cerebral Blood Flow in Apoplexy (Acute Hemiparesis) without Arterial Occlusion
  432. Discussion and Comments to Section XI on Techniques for Measurement of Cerebral Blood Flow
  433. Regional Cerebral Blood Flow in Acute Apoplexy
  434. Measurement of blood–brain barrier in humans using indicator diffusion